SVRA - Savara Inc
3.06
0.060 1.961%
Share volume: 820,207
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$3.00
0.06
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-12-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 22.443 M | 23.157 M | 26.324 M | 31.142 M | |
| Selling general and admin | 5.636 M | 5.540 M | 6.013 M | 7.848 M | |
| Research and development | 16.807 M | 17.617 M | 20.311 M | 23.294 M | |
| Total expenses | 22.475 M | 23.190 M | 26.357 M | 31.174 M | |
| 3.18% | 13.66% | 18.28% | |||
| Operating income | -22.475 M | -23.190 M | -26.357 M | -31.174 M | |
| Ebit | -22.496 M | -23.315 M | -26.377 M | -30.957 M | |
| Pretax income | -21.143 M | -22.243 M | 0.000 | -53.292 M | |
| 5.20% | -100.00% | inf% | |||
| Income tax | -797.000 K | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -20.346 M | -22.243 M | -24.248 M | -29.044 M | |
| -9.32% | -9.01% | -19.78% |
